DAIC

JANUARY 31, 2024

GORE VIABAHN VBX Balloon Expandable Endoprosthesis milla1cf Wed, 01/31/2024 - 17:04 January 31, 2024 — As part of efforts to continuously improve medical solutions for patients with complex vascular disease, W. No changes to the stent design were made to achieve the lower profile. Gore & Associates, Inc. Since its U.S.

Stents 111

Stents Stent Innovation Aortic 111

DAIC

JANUARY 19, 2024

milla1cf Fri, 01/19/2024 - 10:43 January 19, 2024 — W. While stenting is common when treating complex iliac occlusive disease, the question around whether to use a covered or bare metal stent remains a source of debate," said Prakash Krishnan, M.D. Gore & Associates, Inc.

Stents 107

Stents Stent Anatomy Outcomes 107

Cardiology Update

JULY 28, 2024

A recent study published in JACC: Cardiovascular Interventions has provided new insights into the long-term management of patients suffering from recurrent in-stent restenosis (ISR), a condition presenting notable challenges in cardiovascular treatment. 2024 Jan, 17 (1) 1–13. The median follow-up period was 10.3 J Am Coll Cardiol Intv.

Stents 52

Stents Stent Cardiovascular Interventions Research 52

HCPLive

MARCH 1, 2024

The approval of the AGENT Drug-Coated Balloon is based on the AGENT IDE trial and was announced by Boston Scientific on March 01, 2024.

Stents 72

Stents Stent 72

DAIC

MARCH 1, 2024

milla1cf Fri, 03/01/2024 - 08:50 March 1, 2024 — Boston Scientific Corporation today announced it has received U.S. Food and Drug Administration ( FDA ) approval for the AGENT Drug-Coated Balloon (DCB), which is indicated to treat coronary in-stent restenosis (ISR) in patients with coronary artery disease. vs. 28.7%; P=0.006).

Stent 105

Stent Stents Coronary Artery Disease Angioplasty 105

Cardiology Update

JANUARY 7, 2024

Here is our curated list of the top interventional cardiology conferences and courses scheduled for 2024. Additionally, be sure to review the main general cardiology conferences listed in our Top 10 Cardiology Conferences for 2024. Noncoronary topics like structural heart disease and vascular medicine are also addressed.

Interventional Cardiology 64

Interventional Cardiology Innovation Heart Disease Physiology 64

Journal of the American Heart Association

FEBRUARY 26, 2025

Stent performance was assessed.ResultsWe identified 28 patients (67.8% The procedures mostly used 7 Fr sheaths for stents on 6, 7, and 8 mm balloons and 8 Fr sheaths for 9, 10, 12 mm balloons. Median stent expansion percentage was 95% (IQR, 90%96%). Median stent shortening was 1.9% (IQR, 0%3.9%). kg (IQR, 9.116.4).

Stents 45

Stents Stent Stenosis Congenital 45

DAIC

MAY 30, 2024

Clinical success was defined as optimal stent expansion after final treatment with no in-hospital major adverse cardiovascular event (MACE). stent expansion at Maximum Calcium Site 96.7% stent expansion at Maximum Calcium Site 96.7% Shown here: Elixir Medical CEO Motasim Sirhan.

Stent 105

Stent Stents Peripheral Arterial Disease Cardiovascular Disease 105

CardiacWire

MARCH 29, 2025

With the FDA nod, Abbott can now evaluate the IVL system in treating severe calcification in coronary arteries prior to stenting. Notably, FastWaves FIH trial was successful last year, while Amplitudes Pulse IVL system secured its IDE approval in June of 2024.

Plaque 59

Plaque Interventional Cardiology Stent Innovation 59

DAIC

JUNE 18, 2024

Image courtesy: Getty Images christine.book Tue, 06/18/2024 - 11:07 June 18, 2024 — Elixir Medical has announced the company’s novel bioadaptive implant, DynamX Sirolimus-Eluting Coronary Bioadaptor System, has been granted Breakthrough Device Designation by the U.S. Stent Related Adverse Events greater than 1 Year After PCI.

Coronary Artery Disease 105

Coronary Artery Disease Technology Stent Stents 105

Medical Xpress - Cardiology

SEPTEMBER 2, 2024

Novel drug-coated balloons (DCB) did not outshine standard treatment with second generation drug-eluting stents (DES) as they were expected to, in a surprise finding of the first randomized trial to compare clinical outcomes in previously untreated patients with non-complex disease undergoing percutaneous coronary intervention (PCI).

Stents 45

Stents Stent Angioplasty Outcomes 45

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4144093-A4144093, November 12, 2024. Although stents are commonly used with over 3 million stents implanted in cardiovascular arteries every year, there have been minimal efforts to integrate sensing functionality with stents.

Stents 40

Stents Stent Circulation 40

Frontiers in Cardiovascular Medicine

DECEMBER 13, 2024

A total of 9,905 publications from 67 countries were published from 1 January 2014, to 1 March 2024. A total of 2,142 (29.52%) studies were from the United States, 1,293 (13.05%) were from China, and 919 (9.28%) were from the United Kingdom. Abdominal aortic aneurysm was the most frequently used author keyword (2,492).

Aneurysm 52

Aneurysm Aortic Research Download 52

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWMP88-AWMP88, February 1, 2024. Background:In stroke patients undergoing EVT, angioplasty and stenting (A&S) has been described as a bailout technique when thrombectomy fails or intracranial stenosis is suspected. Additionally, 10-15 ml of tirofiban were administered intravenously.

Stents 40

Stents Stent Angioplasty Stenosis 40

American College of Cardiology

SEPTEMBER 2, 2024

A strategy of drug-coated balloon (DCB) angioplasty with rescue stenting did not achieve noninferiority compared with intended drug-eluting stent (DES) deployment for patients with de novo, noncomplex coronary artery lesions, according to finding from the REC-CAGEFREE I trial presented at ESC Congress 2024 in London and simultaneously published in (..)

Angioplasty 40

Angioplasty Stents Stent Article 40

Journal of Cardiovascular Pharmacology

OCTOBER 9, 2024

This study aimed to explore the relationship between in-stent neoatherosclerosis (ISNA) and the neutrophil-to-lymphocyte ratio (NLR) in patients with in-stent restenosis (ISR) following drug-eluting stent (DES) implantation. Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.

Stents 40

Stents Stent Plaque Article 40

DAIC

MAY 6, 2024

milla1cf Mon, 05/06/2024 - 10:55 May 6, 2024 — SMT (Sahajanand Medical Technologies), a leading medical device company at the forefront of innovative patient care in the cardiovascular segment has announced a strategic partnership with HeartX , a pioneering MedTech company focused on research and development.

Congenital 105

Congenital Innovation VSD Stent 105

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWP179-AWP179, February 1, 2024. In cases of stent-retriever thrombectomy failure, rescue stent angioplasty might be the sole option for achieving permanent recanalization. Among patients who underwent emergency intracranial stenting, 66 (30.6%) received intravenous thrombolytic treatment.

Stents 40

Stents Stent Thrombolysis Angioplasty 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4145821-A4145821, November 12, 2024. In this hyperacute emergent clinical situation, covered stents have been considered as a primary measure to prevent further serious arterial events. A fabric-based covered graft stents yield poor clinical outcomes. at 2weeks, 26.1 at 1 year).Conclusion:The

Stents 40

Stents Stent Stenosis Outcomes 40

DAIC

APRIL 8, 2024

The study focused on patients who underwent PCI for acute coronary syndromes (ACS)—life-threatening conditions which include heart attacks and chest pain caused by decreased blood flow to the heart—with stents containing drugs to prevent further plaque buildup. Stents were supplied by Medtronic Corp. Minnesota, U.S.)

Heart Attack 111

Heart Attack Heart attacks Stent Stents 111

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWP6-AWP6, February 1, 2024. Background:Studies have demonstrated that the addition of alteplase for patients with tandem lesions who underwent mechanical thrombectomy and acute stenting was safe with improved outcomes. of MT with carotid stenting alone (aOR 6.92 [0.45-105.7],

Stents 40

Stents Stent Outcomes Thrombolysis 40

DAIC

JULY 11, 2024

christine.book Thu, 07/11/2024 - 10:50 July 11, 2024 — Medical device company R3 Vascular Inc. The company reports these are designed to deliver the ‘stent-like’ support of a scaffold along with the anti-inflammatory and anti-proliferative result of sirolimus, but ‘disappearing’ over time as the vessel heals.

Peripheral Arterial Disease 105

Peripheral Arterial Disease Stent Stents Education 105

The American Journal of Cardiology

MAY 22, 2024

Publication date: Available online 21 May 2024 Source: The American Journal of Cardiology Author(s): Kristopher Aten, Deitrich Gerlt, Zachary Rosol, Subhash Banerjee

Stents 52

Stents Stent 52

The American Journal of Cardiology

JULY 6, 2024

Publication date: Available online 5 July 2024 Source: The American Journal of Cardiology Author(s): Kazumasa Kurogi, Tatsuya Tokai, Yuichiro Shirahama, Nobuyasu Yamamoto, Takeshi Serikawa, Masanobu Ishii, Kenichi Tsujita

Ultrasound 52

Ultrasound Stents Stent 52

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATP214-ATP214, February 1, 2024. In-silico evaluation (computer simulated analysis in a virtual stroke model) has the potential to test and optimize large number of stent-retriever design variations in a relatively time and cost-effective manner.

Stents 40

Stents Stent Blood Clot Anatomy 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4142793-A4142793, November 12, 2024.

Stents 40

Stents Stent Circulation 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWP187-AWP187, February 1, 2024. Background:Persistent hypotension after carotid artery stenting (CAS) can lead to adverse outcomes, prolong length of stay (LOS), and increase hospital costs. Persistent hypotension prolonged LOS (P=0.014).Conclusion:Prior

Stents 40

Stents Stent Blood Pressure Hypertension 40

The American Journal of Cardiology

JULY 18, 2024

Publication date: Available online 18 July 2024 Source: The American Journal of Cardiology Author(s): Safia Shaikh, Mohammad Hamza, Prakash Upreti, Mohammad Akkawi, Kripa Rajak, Mobeen Zaka Haider, Nomesh Kumar, Mustafa Turkmani, Fadi Kathawa, Salman Abdul Basit, Yasemin Bahar, Sadaf Fakhra, Yasar Sattar, M Chadi Alraies

Angioplasty 52

Angioplasty Stents Stent 52

The American Journal of Cardiology

JANUARY 16, 2024

Publication date: Available online 15 January 2024 Source: The American Journal of Cardiology Author(s): Hiroyuki Jinnouchi, Kenichi Sakakura, Yousuke Taniguchi, Kei Yamamoto, Masashi Hatori, Takunori Tsukui, Taku Kasahara, Yusuke Watanabe, Masaru Seguchi, Hideo Fujita

Stents 52

Stents Stent 52

Circulation: Cardiovascular Interventions

NOVEMBER 5, 2024

Circulation: Cardiovascular Interventions, Volume 17, Issue 12 , Page e013964, December 1, 2024. BACKGROUND:Covered stent correction (CSC) of a superior sinus venosus atrial septal defect is an alternative to surgery in selected patients, but anatomic variation means that assessment for CSC requires a 3-dimensional anatomic understanding.

Stents 40

Stents Stent Pulmonary Cardiovascular Interventions 40

The American Journal of Cardiology

JULY 9, 2024

Publication date: Available online 8 July 2024 Source: The American Journal of Cardiology Author(s): Manoj Kumar, Nomesh Kumar, Mobeen Haider, Prakash Upreti, Abdul Rasheed Bahar, Mohammad Hamza, Mustafa Turkmani, Salman Abdul Basit, Kripa Rajak, Carson Middlebrook, Yasemin Bahar, Shafaqat Ali, Yassar Sattar, M. Chadi Alraies

Stents 40

Stents Stent 40

Circulation

MAY 12, 2024

Circulation, Volume 149, Issue 20 , Page e1189-e1190, May 14, 2024.

Stents 45

Stents Stent Circulation 45

DAIC

APRIL 12, 2024

Getty Images milla1cf Fri, 04/12/2024 - 20:55 April 12, 2024 — Simpson Interventions, Inc. , If a physician fails to cross a CTO, minimally invasive revascularization options such as angioplasty and stent placement cannot be performed. Food and Drug Administration ( FDA ).

Technology 111

Technology Cardiovascular Interventions Coronary Artery Disease Innovation 111

Stroke Journal

JANUARY 30, 2025

Background:Hyperperfusion phenomenon (HPP) constitutes a significant risk factor for adverse outcomes following carotid artery stenting (CAS). Stroke, Volume 56, Issue Suppl_1 , Page ATP178-ATP178, February 1, 2025. Currently, the sole method for evaluating the risk of HPP post-CAS is the invasive acetazolamide (ACZ) challenge test.

Stents 40

Stents Stent Stenosis Risk Factors 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4146935-A4146935, November 12, 2024. Inclusion criteria encompassed randomized controlled trials of ticagrelor comparing<3 month of DAPT with 12 month of DAPT in ACS patients undergoing coronary stenting with a minimum follow up of one year.

Stents 40

Stents Stent Circulation Outcomes 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATMP68-ATMP68, February 1, 2024. Purpose:Since the balloon protection device became unavailable in Japan three years ago, the DWI-positive rate after carotid artery stenting (CAS) has increased. Symptomatic stenosis (63.9% vs. 94.7%, p<0.05) was more common in the with-POWER group.

Stents 40

Stents Stent Stenosis Embolism 40

DAIC

JANUARY 31, 2024

Getty Images milla1cf Wed, 01/31/2024 - 17:07 January 31, 2024 — Coronary artery calcification is increasing in prevalence, leading to greater risks both during procedures such as percutaneous coronary intervention (PCI) and adverse events in the short and long term.

Document 108

Document Interventional Cardiology Stent Stents 108